⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NVS News
Novartis AG
Central Nervous System Therapeutic Market Report 2025-2033: Key Drivers, Regional Nuances, Competitive Dynamics | Astute Analytica
globenewswire.com
BMY
MNMD
CYBN
ATAI
NUMI
REGN
NVS
Muscular Dystrophy Association’s Legacy Awards Honor Innovators in Clinical and Scientific Research, and Community Impact at the 2026 MDA Clinical & Scientific Conference in March
globenewswire.com
ARGX
BIIB
BBIO
NVS
RGNX
SCHR
Macrophage Activation Syndrome Market in the 6MM to Witness Upsurge in Growth at a CAGR of 24.7% During the Forecast Period (2025-2034) | DelveInsight
prnewswire.com
NVS
BIIB
VTRS
UCB
BMY
ABBV
REGN
SNY
LLY
JNJ
HOPE
GCBC
AMGN
TAK
Zonsen PepLib Biotech and Novartis Sign Worldwide License Agreement regarding Radioligand Therapy Asset
businesswire.com
NVS
Systemic Lupus Erythematosus Market to Exhibit Growth at a CAGR of 9.4% During the Forecast Period (2025–2034) Owing to Rising Use of Biologics – Approvals of BENLYSTA and SAPHNELO, Plus a Strong Pipeline | DelveInsight
globenewswire.com
JNJ
BIIB
NVS
VTRS
RPRX
ABBV
AZN
MRK
RIGL
GSK
REGN
GILD
AMGN
LLY
BMY
XBI
IBB
Adimab Records Another Year of Double-Digit Clinical Program Growth
prnewswire.com
GSK
BIIB
NVS
BMY
REGN
VRTX
LLY
MRK
ALNY
IVVD
ALE
SCHR
Radiopharmaceuticals Market to Worth Over US$ 13.4 Billion by 2033 | Astute Analytica
globenewswire.com
BMY
AZN
LLY
NVS
MRK
JNJ
Acute Myeloid Leukemia Market Analysis and Forecast, 2025-2035: Precision Medicine Leads Growth
globenewswire.com
NVS
BMY
ABBV
Inflammatory Diseases Biologics Market to Reach USD 157.31 Billion by 2033 as Targeted Immunology Therapies Redefine Long-Term Disease Control
prnewswire.com
AMGN
NVS
JNJ
PFE
GSK
ABBV
SNY
LLY
Atherosclerotic Cardiovascular Disease Market to Register Incremental Growth at a CAGR of 4.9% During the Forecast Period (2025–2034) | DelveInsight
globenewswire.com
AMGN
ARWR
IONS
NVS
NVO
MRK
LLY
REGN
ESPR
ALNY
VRTX
XBI